首页 › 基金 › MidFirst Bank › ABBV

MidFirst Bank 对 ABBV 的持仓历史

ABBVIE INC · 医疗保健

MidFirst Bank 在 Q2 2026 的 13F 申报中披露持有 ABBV(ABBVIE INC)41,007 股,市值约 US$10.3M,约占其申报组合的 0.73%,在其申报持仓中市值排名第 34 位。 MidFirst Bank 最近 3 个申报季度中有 3 个季度披露了 ABBV 持仓,最早可追溯至 Q4 2025。

最新持仓 (Q2 2026)41.01K 股
申报持仓市值$10.32M
组合权重0.73%
首次申报Q4 2025
最近变动增持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

MidFirst Bank 对 ABBV 的持仓演变

MidFirst Bank 于 Q4 2025 首次披露 ABBV 持仓:42,858 股(约 US$9.2M)。 该持仓在 Q2 2026 达到峰值 41,007 股,市值约 US$10.3M。 在 3 次申报中,MidFirst Bank 1 次增持、1 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 41,007 股、市值约 US$10.3M,环比增持 723 股。。

逐季持仓明细

季度股数金额变化
Q4 2025 42.86K $9.24M 新进
Q1 2026 40.28K $8.76M 减持
Q2 2026 41.01K $10.32M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 ABBV 与 13F 数据

ABBV(ABBVIE INC)属于医疗保健行业。我们追踪的基金中还有 35 只申报持有 ABBV,申报仓位最大的包括:先锋集团 (US$41.31B), 贝莱德 (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ABBV 的基金

查看 ABBV 的全部基金持有人 →

常见问题

How long has MidFirst Bank held ABBV?

MidFirst Bank has disclosed ABBV holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is MidFirst Bank's current position in ABBV?

As of Q2 2026, MidFirst Bank holds 41.01K shares of ABBV (ABBVIE INC), valued at $10.32M, representing 0.73% of its reported portfolio and ranking #34.

Has MidFirst Bank been buying or selling ABBV?

In the latest 13F filing (Q2 2026), MidFirst Bank increased its position in ABBV. The position peaked in Q2 2026 at 41.01K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include 先锋集团, 贝莱德, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.